A walking program for outpatients in psychiatric rehabilitation: pilot study (Q23915528)

NIOSHTIC-2

on focus list of Wikimedia project

2 February 2024

Wikimedia–NIOSH collaboration

0 references

1 reference

25 September 2023

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Benefits of lifestyle activity vs structured exercise

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

A community ability scale for chronically mentally ill consumers: Part I. Reliability and validity.

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Weight gain from novel antipsychotic drugs: need for action

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

The unhealthy lifestyle of people with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Assessing motivational readiness and decision making for exercise

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Cardiovascular risk factors for people with mental illness

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Depression in schizophrenia: nursing care as a generalized resistance resource

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Exercise as an adjunct treatment for schizophrenia: A review of the literature

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Outcome expectations for exercise scale: utility and psychometrics

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Novel antipsychotics and severe hyperlipidemia

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

The association of medical comorbidity in schizophrenia with poor physical and mental health.

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Neurocognitive correlates of helplessness, hopelessness, and well-being in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Reliability and validity of the SF-12 health survey among people with severe mental illness.

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Increasing physical activity: a quantitative synthesis

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Is physical activity or physical fitness more important in defining health benefits?

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Exercise characteristics and the blood pressure response to dynamic physical training

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Response of blood lipids to exercise training alone or combined with dietary intervention

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Physical activity dose-response effects on outcomes of depression and anxiety

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Stigma as a barrier to recovery: The consequences of stigma for the self-esteem of people with mental illnesses.

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Stigma as a barrier to recovery: Adverse effects of perceived stigma on social adaptation of persons diagnosed with bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Measuring adherence to a women's walking program.

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Therapeutic impact of exercise on psychiatric diseases: guidelines for exercise testing and prescription

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Screening for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

The distribution of body mass index among individuals with and without schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

Determinants of overweight and obesity in patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1177%2F1099800405278116

7 January 2021

release_o6b4rnmxwfholpf2jzxhm4krxe

Identifiers

DOI

10.1177/1099800405278116

1 reference

16 August 2019

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o6b4rnmxwfholpf2jzxhm4krxe

24 November 2022